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‡To whom correspondence should be addressedIn developing mouse embryos, MyoD family regulatory
genes are expressed specifically in muscle precursors
and mature myofibers. This pattern, taken together with
the well-established ability of MyoD family members to
convert a variety of cell types to skeletal muscle, sug-
gests a significant role for these genes in regulating
skeletal myogenesis. The possibility that expression of
these genes may be causally associated with segregation
of the myogenic lineage from other mesodermal deriv-
atives, or with the subsequent maintenance of muscle
phenotypes at later times, raises the issue of how MyoD
family genes are themselves regulated during develop-
ment. In this work, we have initiated studies to identify
DNA sequences that govern Myf-5 and MRF4 (herculin,
myf-6) transcription. Myf-5 is the first of the MyoD
family to be expressed in the developing mouse embryo,
while MRF4 is the most abundantly expressed myogenic
factor in postnatal animals. In spite of their strikingly
divergent patterns of expression, Myf-5 and MRF4 are
tightly linked in the mouse genome; their translational
start codons are only 8.5 kilobases apart. Here, the 5′
flanking regions of the mouse Myf-5 and MRF4 genes
were separately linked to a bacterial β-galactosidase
(lacZ) gene, and these constructs were each used to pro-
duce several lines of transgenic mice. Transgene expres-
sion was monitored by X-gal staining of whole embryos
and by in situ hybridization of embryo sections. For the
Myf-5/lacZ lines, the most intense transgene expression
was in the visceral arches and their craniofacial muscle
derivatives, beginning at day 8.75 post coitum (p.c.).
This correlates with endogenous Myf-5 expression in
visceral arches. However, while Myf-5 is also expressed
in somites starting at day 8 p.c., transgene expression in
the trunk is not observed until day 12 p.c. Thus, the
Myf-5/lacZ construct responds to early Myf-5 activators
in the visceral arches but not in the somites, suggesting
that myogenic determination in the nonsomitic head
mesoderm may be under separate control from that of
the somitic trunk mesoderm. MRF4/lacZ lines displayed
an entirely different pattern from Myf-5. Transgene
expression appeared in muscles starting at day 16.5 p.c.
and became increasingly prominent at later times. How-
ever, an early wave of myotomal expression that is char-
acteristic of the endogenous MRF4 was not recapitu-
lated by the transgene. 
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SUMMARYINTRODUCTION
Skeletal muscle is one of many derivatives of mesoderm in
vertebrates. Muscles of the head originate from prechordal
and paraxial mesodermal cells (Noden, 1991; Couly et al.,
1992), most of which populate the visceral arches and then
migrate into the developing head. Muscles of the trunk and
limbs arise from the somites, which are segmental blocks
of paraxial mesoderm that form in pairs on either side of
the neural tube (Lyons and Buckingham, 1992; Ordahl and
Le Douarin, 1992).
An important contribution to the current view of skele-
tal myogenesis came from the cloning of MyoD (Davis etal., 1987; Tapscott et al., 1988) and its three close relatives,
myogenin (Wright et al., 1989; Edmondson and Olson,
1989), Myf-5 (Braun et al., 1989) and MRF4/herculin/Myf-
6 (Rhodes and Konieczny, 1989; Miner and Wold, 1990;
Braun et al., 1990). These genes encode transcription fac-
tors of the basic-helix-loop-helix (B-HLH) family (Murre
et al., 1989) that bind in vitro to consensus ‘E-box’ recog-
nition sites. These sites are prominent and functionally sig-
nificant in many genes expressed specifically in differenti-
ated muscle (Murre et al, 1989; Weintraub et al, 1991).
Forced expression of any of the MyoD family genes in a
variety of nonmuscle cultured cells can convert them to a
skeletal muscle phenotype, suggesting that these regulators
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of skeletal muscle (Olson, 1990; Weintraub et al., 1991).
The ability of ectopic MyoD and/or Myf-5 to activate skele-
tal muscle-specific genes in developing Xenopus embryos
(Hopwood and Gurdon, 1990; Hopwood et al., 1991) and
in the hearts of transgenic mice (Miner et al., 1992) sup-
ports this view. 
Analysis of the expression of these myogenic regulatory
genes in several cultured skeletal muscle cell lines has
revealed that proliferating myoblasts, which are determined
to form muscle, express MyoD (MM14 [Mueller and Wold,
1989]), Myf-5 (L6, BC3H1 [Braun et al., 1989; Mueller
and Wold, 1989]), or both (C2C12 [Braun et al., 1989;
Miner and Wold, 1990]), while their differentiated coun-
terparts express myogenin always (Emerson, 1990) and
MRF4 sometimes (L6J1-C, C2C12 [Rhodes and
Konieczny, 1989; Miner and Wold, 1990]). However, it is
not at all clear how these few established cell lines are
related to muscle and its progenitors in the animal. In situ
hybridization experiments on mouse embryo sections have
shown that there is a complex pattern of sequential accu-
mulation and disappearance of MyoD family RNAs in
developing muscle, and that the pattern varies among dif-
ferent skeletal muscle groups (for review see Buckingham,
1992). Myf-5, the earliest marker of muscle, is first detected
at 8 days p.c. in anterior somites, just before the myotome
can be recognized as distinct from sclerotome and dermo-
tome by cytological criteria (Ott et al., 1991). Similar
expression is sequentially observed in more posterior
somites as these structures form in their characteristic ros-
tral-caudal sequence. Myf-5 RNA is subsequently detected
at day 9.25 p.c. in the hyoid arch and is followed at day
10 p.c. in the mandibular arch and at day 10.5 p.c. in the
forelimb bud. Myogenin and MyoD are expressed in all
muscle masses following Myf-5 activation. In contrast,
MRF4 is never detected in visceral arches or limb buds by
in situ hybridization. However, a wave of transient MRF4
RNA expression is observed in myotomes between days 9
and 11.5 p.c. (Bober et al., 1991; Hinterberger et al., 1991).
Late in development, Myf-5 expression declines and
becomes undetectable by day 14 p.c. and remains that way
(Ott et al., 1991), while MRF4 reappears at day 16 p.c. in
all fetal skeletal muscles and becomes the predominant
MyoD family regulatory gene expressed in the adult
(Rhodes and Konieczny, 1989; Miner and Wold, 1990;
Bober et al., 1991; Hinterberger et al., 1991). 
The basis for the complex and stringently controlled pat-
tern of differential expression of the MyoD family of regu-
lators is not well understood. Studies of genomic regulatory
elements have mainly concentrated on the myogenin and
MyoD genes. Remarkably, only 200 base pairs of proximal
5′ flanking sequence from the myogenin gene were suffi-
cient to direct myocyte-specific expression (Salminen et al.,
1991). The emerging picture for human MyoD is quite dif-
ferent. Its 5′ flank has been tested for regulatory activity in
both cell culture and in transgenic mice. Experiments in cul-
tured cells led to the identification of a region positioned
between 18 and 22 kb upstream of the coding region which
enhanced transcription from the proximal MyoD promoter
in 23A2 myoblasts but also, surprisingly, in their nonmyo-
genic parental cell line C3H 10T1/2, where endogenousMyoD is not normally expressed. In spite of the apparently
inappropriate expression in nonmyogenic cultured cells, this
enhancer element drove expression in a muscle-restricted
pattern in transgenic mice (Goldhamer et al., 1992).
In contrast to MyoD and myogenin, little is presently
known about the regulation of MRF4 and Myf-5. Myf-5 tran-
scripts appear before any of the other MyoD family RNAs
(Ott et al, 1991). MRF4 is most notably expressed in late
fetal and postnatal muscle where it quantitatively predom-
inates over the other MyoD family transcripts (Miner and
Wold, 1990), suggesting a role for MRF4 in maintenance
of differentiated muscle. Furthermore, the close physical
linkage of Myf-5 and MRF4, presumably the result of an
ancient gene duplication, presents an interesting problem in
the evolution, organization and utilization of regulatory ele-
ments. The two genes share a stringent specificity for
expression in skeletal muscle, but show highly disparate
developmental regulation. In preliminary experiments, we
found expression of reporter genes carrying Myf-5 and
MRF4 flanking sequences in cultured cell lines to be min-
imal. To overcome this assay limitation and to gain access
to the full developmental diversity of MRF4 and Myf-5
expressing cells in the animal, we have produced transgenic
mice expressing the reporter constructs. These experiments
have allowed us to identify sequence elements from Myf-5
and MRF4 that specify expression in their distinct, spatially
and temporally restricted patterns.
MATERIALS AND METHODS
Construction of the transgenes
5.5 kb of the 5′ flanking region of the mouse Myf-5 gene were
isolated as a BamHI to SacI fragment from the original mouse
Myf-5/herculin phage described previously (Miner and Wold,
1990). This fragment contains the Myf-5 proximal promoter and
putative transcription start site (Ott et al., 1991). A bacterial β-
galactosidase gene containing an introduced consensus Kozak
translation initiation sequence was placed downstream of this in
Bluescript II KS+ (Stratagene) to make MYF5Z. 
The original Myf-5/herculin phage contained only about 350
base pairs of herculin (MRF4) 5′ flanking DNA. Genomic South-
ern blots (J. M., unpublished) had indicated the existence of
another BamHI site approximately 10 kb upstream of the previ-
ously identified site (Miner and Wold, 1990), or 6.5 kb upstream
of the MRF4 coding region. We cloned this 10 kb BamHI frag-
ment by constructing a phage lambda library from ~9-11 kb
BamHI fragments of mouse genomic DNA (electroeluted from an
agarose gel) using the vector lambda gem-12 (Promega). The
library was probed with the MRF4 transcribed region, and the
insert of a positive phage was subcloned into Bluescript II KS+.
Restriction analysis showed that this phage contained the MRF4
coding region as well as 6.5 kb of 5′ flanking DNA, as expected.
To be sure of including the MRF4 transcription start site in the
lacZ construction, we used the ~6.5 kb BamHI to SalI fragment
as a foundation and then ligated 52 base pairs of additional con-
tiguous sequence, synthesized as two complementary oligonu-
cleotides by the Caltech Microchemical Facility. This sequence
was added because preliminary primer extension assays (J. M.,
unpublished) had indicated that it should contain the major tran-
scription start site. Therefore, the 3′ end of the mouse MRF4
sequences used here is nucleotide 64 of the reported herculin
genomic sequence (Miner and Wold, 1990).
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Fig. 1. Structure of the mouse MRF4/Myf-5 locus and the
respective transgenes. The stippled areas approximate transcribed
regions, but for Myf-5 only the location of the first exon is known.
lacZ segments are not drawn to scale. See Materials and Methods
for construction details. B, BamHI; R, EcoRI; K, KpnI. Preparation of DNA and production of transgenic
mice
MYF5Z and MRF4Z plasmids were purified by cesium chloride
density gradient ultracentrifugation. To liberate the constructs
from vector sequences, MYF5Z was cut with KpnI, BamHI and
ScaI, and MRF4Z was cut with BamHI and XhoI. To isolate the
fragments for microinjection, the restriction digests were loaded
onto 10-40% preformed sucrose gradients and ultracentrifuged in
a SW41 rotor at 26,000 revs/minute for 24 hours (Maniatis et al.,
1982). 300 µl fractions were collected and analyzed by agarose
gel electrophoresis. DNA was ethanol-precipitated out of the
appropriate fractions and dissolved in 10 mM Tris (pH=7.5), 0.1
mM EDTA (pH=8). Transgenic mice were produced by pronu-
clear microinjection of single cell mouse embryos from a
(C57BL/6×DBA/2)F1×(C57BL/6×DBA/2)F1 cross as described
(Hogan et al., 1986; Miner et al., 1992).
Analysis of transgenic mice
Transgenic founder mice were identified by Southern blot or poly-
merase chain reaction analysis of tail DNA. Male founders and
male offspring of female founders were mated in most cases with
C57BL/6×DBA/2 hybrid females, though sometimes the parental
inbred strains were used. For postnatal analyses, pups of various
ages were killed, skinned, fixed in 4% formaldehyde in phosphate-
buffered saline (PBS) and stained in PBS containing 35 mM potas-
sium ferricyanide, 35 mM potassium ferrocyanide, 1.5 mM mag-
nesium sulfate, and 1 mg/ml X-gal (US Biochemicals Corp.)
overnight at 37°C. For prenatal analyses, timed pregnant females
were killed at the desired day of gestation, and embryos were dis-
sected out of the uterine horns into PBS. They were fixed and
stained as above, though for older embryos the staining solution
was supplemented to contain 0.2% sodium deoxycholate and 0.1%
Nonidet P-40 to enhance X-gal penetration.
In situ hybridization
In situ hybridization was performed on 5 to 7 µm paraffin sec-
tions. The procedures used for section treatment, hybridization and
washings are described by Lyons et al. (1990). Hybridizations
were carried out at 50°C for ~16 hours in 50% deionized for-
mamide, 0.3 M NaCl, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA,
10 mM sodium phosphate (pH 8), 10% dextran sulfate, 1× Den-
hardt’s solution, 50 µg/ml of yeast RNA, with 50-75,000
cts/minute/µl of cRNA labeled with 35S-labeled UTP (>1000
Ci/mmole, Amersham). Washing was at 65°C in 50% formamide,
2× SSC, and 10 mM DTT. Slides were then treated with RNase
A (20 µg/ml) (Boehringer Mannheim) for 30 minutes at 37°C.
After washes, slides were processed for standard autoradiography
with Kodak NTB-2 nuclear track emulsion and exposed for 7 days.
Analysis was carried out with both light- and dark-field optics on
a Zeiss Axiophot microscope.
For the Myf-5 probe, a 310-bp BalI-ApaI fragment of the first
exon of the mouse Myf-5 gene was used as described by Ott et
al. (1991). For the MRF4 probe, the 680 bp 3′ PstI fragment of
the mouse gene was used as described by Bober et al. (1991). For
the lacZ probe, the 3 kb BssHII fragment of the MRF4Z construct,
which also contains the SV40 polyadenylation signal sequence,
was used.
RESULTS
Production of transgenic mice
5.5 kb of Myf-5 and 6.5 kb of MRF4 5′ flanking regions
were each linked to the bacterial β-galactosidase gene.
These constructs (Fig. 1) are called MYF5Z and MRF4Z,respectively. Multiple transgenic lines were produced by
pronuclear microinjection. All four DNA-positive lines pro-
duced with the MYF5Z construct expressed the transgene;
two of the four lines, MYF5Z-21 and MYF5Z-29, showed
the most intense β-galactosidase (β-gal) staining and hence
were more comprehensively characterized. The two other
lines, MYF5Z-9 and MYF5Z-46, showed an overlapping
but reduced expression pattern. Seven MRF4Z transgenic
lines were produced: three (MRF4Z-28, -45 and -49)
expressed the transgene in a muscle-specific manner, three
did not express the reporter gene at all, and a single line,
called MRF4Z-4, exhibited ectopic expression in several
diverse tissues characteristic of strong, site-of-insertion
position effects (Allen et al., 1988; Gossler et al., 1989).
MYF5Z trangenic mice
To survey developmental expression patterns of the trans-
gene in detail, we used histochemical staining for β-gal
beginning at day 8.75 p.c. (E8.75) and continuing through
birth. This assay is highly sensitive and parallel controls
showed all staining, except inside the gut of postnatal pups,
to be specified by the activity of the transgene. The E8.75
(15 somites) embryos examined from MYF5Z-21 and -29,
the two best-expressing lines, contained β-gal-positive cells
in the hyoid and mandibular arches but not in somites (Fig.
2A). Since prior in situ hybridizations had shown that Myf-
5 transcripts begin to accumulate in somites at E8.0 and in
visceral arches at E9.25 (Ott et al., 1991), it appears that
this construct contains sequences sufficient to specify the
early visceral arch expression, but insufficient to drive early
somitic expression. As development proceeded, both the
number of cells expressing lacZ and the intensity of expres-
sion increased. At E10.5, the hyoid arch exhibited very
intense expression, and β-gal-positive cells were visible in
the developing ocular muscles (Fig. 2B). At E12, myotomal
staining became detectable, then increased in intensity at
E12.5 (Fig. 2C). Also at E12.5, staining was visible in the
developing muscles of the head which are derived from the
visceral arches and in the muscle masses of the proximal
forelimb. When myotomal expression of the transgene
becomes detectable, it already encompasses the full length
of the embryo (Fig 2C,D), so the anterior-posterior
sequence of endogenous Myf-5 activation that corresponds
to early myotome segregation is not recapitulated by the
transgene. Transgene expression was most prominent at
E13.5 with the appearance of β-gal-positive cells in the
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2D). Beginning at day 14, when endogenous Myf-5 RNA
levels begin to decrease (Ott et al., 1991), muscle-specific
lacZ expression declined and became undetectable shortly
after birth (data not shown). The expression patterns
described were present in at least two different transgenic
lines (Fig. 2D,E), confirming that the transgene expression
in these tissues resulted from regulatory elements present
in the MYF5Z construct, not from site-of-integration posi-
tion effects. This β-gal pattern reflects a substantial subsetFig. 2. Whole-mount histochemical staining of MYF5Z embryos at 
21 embryo. The hyoid arch and the mandibular arch are positive for 
is the most intensely stained structure and staining is also visible in 
specific to MYF5Z-21 embryos is observed in the nervous system as
MYF5Z-21 embryo. Staining is evident in muscular derivatives of th
forelimb muscles, and in the segmented myotomes. Additional ectop
embryo. Staining is similar to that observed in C, with additional mu
dorsal neck and head muscles. Ectopic lacZ expression is observed i
staining is identical to that observed in D, indicating that this stainin
found at the site of integration. f, forebrain, h, hyoid arch, icm, inter
arrowhead, myotome.of the endogenous Myf-5 expression pattern as described
previously by in situ hybridization (Ott et al., 1991). 
To compare endogenous and transgene expression
directly, and to verify the sensitivity of the whole-mount
embryo X-gal staining assay, E11.5 and E12.5 embryos
from MYF5Z-21 and MYF5Z-29 transgenic lines were sec-
tioned, and in situ hybridization experiments with Myf-5
and lacZ probes were performed on adjacent sections. The
lacZ expression pattern observed in these experiments was
identical to the whole-embryo X-gal staining pattern. Invarious developmental stages. (A) A 15 somite (E8.75) MYF5Z-
lacZ transcripts. (B) E10.5 MYF5Z-21 embryo. The hyoid arch
the mandibular arch and in the ocular muscles. Ectopic staining
 well as in the epithelium of the forelimb-bud. (C) E12.5
e visceral arches, in the ocular muscles, in developing proximal
ic expression is observed in the forebrain. (D) E13.5 MYF5Z-21
scle-specific staining in intercostal, proximal hindlimb, and
n the ribs. (E) E13.5 MYF5Z-29 embryo. Muscle-specific
g is due to regulatory sequences in the transgene and not those
costal muscles, m, mandibular arch, om, ocular muscles, r, rib,
65Myf-5 and MRF4 regulatory sequences in transgenic micemost cases, Myf-5 and lacZ RNA distribution was similar,
with lacZ representing a subset of the endogenous Myf-5
expression. At E11.5 (Fig. 3A,B), head muscles were pos-
itive with both Myf-5 and lacZ probes, while somitic expres-
sion was observed only with the Myf-5 probe. At E12.5
(Fig. 3C,D), trunk muscles as well as the proximal fore-
limb muscles expressed the transgene.Fig. 3. Expression of Myf-5 and lacZ in MYF5Z transgenic
embryos as detected by in situ hybridization. (A,B) Parasagittal
sections of E11.5 MYF5Z-21 embryo hybridized to Myf-5 (A) and
lacZ (B) probes. Both Myf-5 and lacZ transcripts are expressed in
jaw (jm) and shoulder (sm) muscles, while only Myf-5 shows
significant hybridization in intercostal muscles (icm) and tail
somites (s) at this stage. While lacZ is expressed in ocular muscles
(om), these muscles are not present in the more lateral section (A)
probed with Myf-5. Notice that the pigment layer of the retina
refracts under dark-field illumination. Some ectopic expression of
lacZ is observed in the neural tube (nt), dorsal ganglia
(arrowheads) and surrounding the heart. (C,D) Frontal sections of
an E12.5 MYF5Z-29 embryo hybridized to Myf-5 (C) and lacZ
(D) probes. Both Myf-5 and lacZ transcripts are expressed in the
back (bm) and limb muscles (lm), with limb muscles showing
more intense signal with the Myf-5 probe than with the lacZ
probe. The transgene also shows some faint ectopic expression in
the heart (h) and neural tube (nt) which was not observed in the
whole-embryo X-gal assay. li, liver. Scale bar = 500 µm.In individual MYF5Z transgenic lines, lacZ was
expressed ectopically in a few non-skeletal muscle tissues
(Fig. 2B-D, 3B,D), as observed by both whole-mount stain-
ing of embryos with X-gal and in situ hybridization exper-
iments. Since these expression patterns were each charac-
teristic of one line only, and not shared by any of the other
three transgenic lines (Fig. 2D,E), we suggest that the
observed ectopic expression is probably due to enhancer
elements trapped near the insertion site of the construct
(Lacy et al., 1983; Kothary et al., 1988; Al-Shawi et al.,
1990). 
MRF4Z transgenic mice
Three MRF4Z lines expressed the lacZ transgene in multi-
ple muscle groups beginning at E16 (data not shown).
Expression of the transgene increased throughout the peri-
natal period (Fig. 4) in parallel with the observed pattern
of endogenous MRF4 expression (Bober et al., 1991; Hin-
terberger et al., 1991). However, MRF4Z transgenic mice
did not express the transgene transiently in embryonic
myotomes as the endogenous MRF4 gene is expressed.
Some muscles expressed the MRF4Z transgene more
intensely than others. For example, muscles of the limbs
showed faint β-gal staining (Fig. 4A), whereas the spin-
odeltoideus muscle (Fig. 4A), levator auris longus muscle
(Fig. 4B), and intervetebral muscles (Fig. 4C) expressed
lacZ particularly strongly. To compare the spatial distribu-
tion of the endogenous MRF4 and lacZ transcripts, abdom-
inal muscles were dissected and in situ hybridization reac-
tions were performed with MRF4 and lacZ probes on
adjacent sections (Fig. 5). Both MRF4 and lacZ transcripts
were detected in all muscle fibers, but showed no activity
in the nearby connective tissue.
Because three of four independent transgenic MRF4Z
lines exhibited the same general patterns of lacZ expres-
sion, and because this pattern parallels that of endogenous
MRF4, we attribute this expression to regulatory sequences
present in the transgene. However, one MRF4Z line,
MRF4Z-4, expressed lacZ in a different and unexpected
fashion (Fig. 6). With the exception of the spinotrapezius
muscle, which expressed intensely starting at E16, MRF4Z-
4 transgene expression did not correlate with the endoge-
nous MRF4 pattern (Bober et al., 1991; Hinterberger et al.,
1991) or with the other MRF4Z lines. Instead, this line
expressed lacZ in a variety of other tissues at different
developmental time periods including vibrissae (Fig. 6A),
hand pads, olfactory bulbs, knee and elbow joints (Fig. 6A)
and mid-brain. This diversity suggests a dominant position
effect coupled, perhaps, with damage to one or more copies
of the transgene.
DISCUSSION
The MyoD family of regulators have been inferred to play
a significant role in skeletal myogenesis. Three lines of evi-
dence support this idea. First, all four MyoD family mem-
bers can recruit diverse cultured nonmuscle cells to a skele-
tal muscle phenotype (Olson, 1990; Weintraub et al., 1991),
and both MyoD and Myf-5 have been shown to be capa-
ble of activating skeletal muscle genes ectopically in devel-
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Fig. 4. Whole-mount X-gal
histochemical staining of MRF4Z
postnatal mice. (A) A lateral view of
the trunk of a 2-day-old MRF4Z-28
mouse pup. Most muscles of the trunk
contain fibers that are positive for lacZ
activity, including latissimus dorsi,
pectoralis and the abdominals. The
spinodeltoideus muscle (s) is
consistently the most intensely stained
in MRF4Z transgenics; the limbs
exhibit considerably less lacZ activity.
(B) An enlarged dorsal view of the
same pup showing staining in muscles
of the head and the neck. (C) A dorsal
view of the trunk of a 7-day-old
MRF4Z-45 pup. Most muscles are β-
gal positive; staining is striking in the
paired intervertebral muscles
(arrowheads) along the anterior-
posterior axis. The top is anterior in all
three cases.oping embryos (Hopwood and Gurdon, 1990; Hopwood et
al., 1991; Miner et al., 1992). This argues for a direct or
indirect role for the MyoD family in the myogenic deter-
mination process. Second, molecular studies suggest a
direct interaction between MyoD family regulators and
transcriptional enhancers of many terminally differentiated
muscle-specific genes (Olson, 1990; Weintraub et al.,
1991). This is consistent with a direct and ongoing role in
execution and maintenance of terminal muscle differentia-
tion. Finally, the MyoD family of transcription factors
(most notably Myf-5) are expressed early in premuscle cells
(Sassoon et al., 1989; Ott et al., 1991; Bober et al., 1991;
Hinterberger et al., 1991), which reinforces a role for these
regulators in myogenic determination prior to overt differ-
entiation of muscle. However, little is known about the mol-
ecular and cellular processes that govern the segregation of
the myogenic lineage from other mesodermal derivatives in
the developing mouse embryo. If the activities of these
MyoD family regulatory proteins are partly or wholly
responsible for establishing the skeletal muscle phenotype,
then learning how expression of these regulators is initi-
ated, maintained, and terminated during embryogenesis is
crucial for understanding how myogenic cell fate is speci-
fied and executed. Apart from the postulated importance of
MyoD family products in regulating myogenesis, their com-
plex and diverse patterns of expression during development
make them very useful markers for distinct subdivisions of
myogenic populations.
Here we have identified DNA sequences from the Myf-
5/MRF4 locus that direct expression of the bacterial β-Fig. 5. MRF4 and lacZ transgene expression in abdominal muscle
sections of a 6.5-day-old MRF4Z-45 transgenic pup as detected
by in situ hybridization. (A) A phase-contrast micrograph of a
section showing abdominal muscle fibers (m) associated with
some adjacent connective tissue (ct). (B) Dark-field micrograph of
A hybridized with the lacZ probe. (C) Dark-field micrograph of an
adjacent section hybridized with the MRF4 probe. All muscle
fibers are positive with both probes, while the connective tissue
associated with the muscle is negative. Scale bar = 100 µm.
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Fig. 6. Whole-mount histochemical
staining of the MRF4Z-4 transgenic mice
demonstrates presumed insertion site-
dependent expression specific to this
transgenic line. (A) E15.5 embryo.
Staining is evident in the vibrissae
(whisker pads), around the opening of the
mouth, and in connective tissue of the
elbow and the knee. The only muscle
staining observed in this line is in the
spinotrapezius muscle of the back. (B) A
dorsal view of the trunk of a 2-day-old
pup showing intense staining of the
spinotrapezius muscle of the back.
Staining in elbow and knee connective
tissue persists.galactosidase gene in patterns reflecting that of endogenous
Myf-5 and MRF4. The MYF5Z transgenic mice, which car-
ried 5.5 kb of upstream Myf-5 sequences, expressed the lacZ
reporter gene in a large subset of the cells which express
endogenous Myf-5 RNA. Myf-5, the earliest known marker
for myogenic precursors, is initially expressed in a group
of cells in somites and visceral arches which later become
muscle cells of the trunk and head, respectively (Ott et al.,
1991). Our results suggest that visceral arch expression of
Myf-5 is under separate control from early Myf-5 expres-
sion in the somite, since we have shown that Myf-5 visceral
arch regulation is recapitulated in our construct, but early
somitic expression is not. Although confirmation will
require isolation of sequences that do direct early somitic
expression, the clear implication is that there are distinct
regulatory pathways by which Myf-5 expression, and per-
haps muscle determination, is initiated in somitic trunk
versus unsegmented head mesoderm. In a similar vein,
expression of Myf-5 observed in our experiments subdivides
somitic expression by time (early versus late) and by the
subset of somitic Myf-5-positive cells that also show lacZ
expression by in situ hybridization. In addition, the failure
of this MYF5Z construct to be expressed when transfected
into C2C12 cells (A.P., unpublished), which do express
some endogenous Myf-5 (Miner and Wold, 1990), is con-
sistent with the organization of Myf-5 control regions into
multiple segregated regulatory elements, and it is likely that
only a subset of these are included in this construct. 
The MRF4Z transgenic mice expressed the transgene in
muscle cells of embryos starting at E16.5, and the intensity
of β-gal staining increased through the first week of post-
natal development. This general expression pattern reflects
that of endogenous MRF4 as determined by in situ
hybridization and northern blot experiments (Bober et al.,
1991; Hinterberger et al., 1991). However, endogenous
MRF4 also displays a separate, transient expression pattern
in myotome between E9 and 11.5 (Bober et al., 1991; Hin-
terberger et al., 1991), but we did not detect any somitic
expression of the transgene in MRF4Z lines. Interestingly,this construct, when transfected into C2C12 cells, which
express some endogenous MRF4 upon differentiation
(Miner and Wold, 1990), is active only in the presence of
high concentrations of cotransfected MyoD family regula-
tory factors (A.P., unpublished). Thus, for both MRF4 and
Myf-5, sequences that normally regulate early myotomal as
well as C2C12 transcription were apparently not included
in the constructs. Of course there are additional mechanisms
of regulation that may contribute to differences between
transgene expression and endogenous RNA levels, includ-
ing specific methylation of sequences within the transgene,
or post-transciptional mechanisms such as RNA stability.
It is also possible that all regulatory regions are present in
our constructs but are dependent on the linked state of Myf-
5 and MRF4.
In these experiments, some ectopic β-galactosidase was
observed in individual lines and was not reproduced in other
transgenic lines with the same construct. This raises the
general issue, crucial in experiments of this design, of
proper attribution of transgene expression patterns. Two cri-
teria were applied to assign expression to the elements from
MRF4 and Myf-5. First, for any pattern attributed to the
construct, transgene expression was observed in indepen-
dent transgenic lines carrying the same construct, arguing
that the signal was due to the construct itself and not to
position effects at the site of insertion. The second crite-
rion was to compare directly the transgene expression pat-
tern with that of the endogenous gene by in situ hybridiza-
tion. In this study, all elements of transgene expression that
were shared by multiple lines of transgenic mice from the
same construct also correlated with RNA expression from
their respective endogenous genes, supporting the idea that
the elements used in these experiments represent true reg-
ulatory regions of Myf-5 and MRF4. In situ hybridization
experiments were especially informative in the MRF4Z
pups where penetrance of histochemical reagents into more
mature muscle became a technical limitation. The line-spe-
cific ectopic transgene expression patterns were most likely
due to adventitious enhancer trapping, in which the con-
68 A. Patapoutian and othersstruct integrates near one or more endogenous, active genes
and the site of integration exerts some regulatory influence
over the transgene (Lacy et al., 1983; Kothary et al., 1988;
Al-Shawi et al., 1990). Three of 11 lines displayed posi-
tion effect phenomena at some stage of development, with
two other lines, MYF5Z-21 and MYF5Z-29, showing some
ectopic expression together with the expected pattern. In
the most extreme case, MRF4Z-4, the typical MRF4 pat-
tern was almost entirely suppressed and a wide array of
ectopic sites were substituted. Curiously expression in just
one major muscle, the spinotrapezius (Fig. 6), was very
prominent, and correlated with the temporal regulation of
the endogenous MRF4.
Of the isolated regulatory elements, perhaps the most
interesting is the Myf-5 5′ flank, which responds to early
signals in the developing head; it will be interesting to
more narrowly define the sequences responsible. Since
craniofacial muscles are derived from unsegmented parax-
ial mesoderm (Couly et al., 1992) and not from the somitic
mesoderm that gives rise to trunk and limb muscles, a reg-
ulatory element that responds to early myogenic signals in
the head but not in the somites may ultimately permit mol-
ecular-level description of how these two myogenic lin-
eages are differentially specified. Also, while cell culture
experiments have shown that forced expression of any of
the four MyoD family regulators can initiate a myogenic
pathway, the issue of whether individual regulators are
functionally different in vivo remains open and will require
both gain-of-function and loss-of-function manipulations.
The cis-regulatory segments defined here should serve as
effective tools for testing the in vivo consequences of
specifically altering the expression pattern of myogenic
regulators by, for example, expressing MRF4 in visceral
arches and their derivatives.
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